PMD Device Solutions Investor Relations Material
Latest events
Q4 2022
PMD Device Solutions
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from PMD Device Solutions
Access all reports
Promore Pharma AB, a biopharmaceutical company, develops therapeutic peptides for the bio-active wound care market in Sweden and internationally. The company offers Promogran Prisma, a collagen-based matrix; RESTORE collagen matrix, a synthetic medical device; PromoFoam matrix, a calcium alginate wound dressing; PAH250 Woundhance, a pharmaceutical agent used in the treatment of chronic wounds; and CytoMend, a resorbable extracellular matrix. It is also developing Platelet Rich Plasma (PRP), which has new functions for patients with chronic wounds; and Aktipak, which is indicated for treating acute deep wounds in conjunction with surgery/suture and debridement/wound bed preparation.
Latest articles
Bill Gates: The Man Who Put a Computer in Every Home
Explore the life of Bill Gates, from co-founding Microsoft to global philanthropy, and his lasting impact on the world.
2 May 2024
The Lego Story: Building a Business Brick by Brick
A detailed account of the most important milestones in the Lego Group's history, as well as an explanation of the philosophy guiding the company
2 May 2024
Kevin Plank and the Rise of Under Armour
Dive into the story of Under Armour and its founder Kevin Plank, highlighting both successes and mistakes.
30 Apr 2024
Ticker symbol
Country
🇸🇪 Sweden